Skip to main content
Synbiotic SE logo

Synbiotic SE — Investor Relations & Filings

Ticker · SBX ISIN · DE000A3E5A59 LEI · 48510041U2G1IWA3R418 F Manufacturing
Open in API
Filings indexed 140 across all filing types
Latest filing 2024-11-22 M&A Activity
Country DE Germany
Listing F SBX

About Synbiotic SE

https://www.synbiotic.com/

Synbiotic SE is a European corporate group focused on the medical cannabis and industrial hemp markets. The company operates a platform model, making strategic investments in ventures across these sectors to create synergies. Its business is vertically integrated, covering the entire value chain from cultivation, research, and development to the production, sales, and distribution of hemp- and cannabinoid-based products. The company's portfolio includes a wide range of high-quality hemp, CBD, and cannabis products, leveraging its expertise across the full supply chain from seed to shelf.

Recent filings

Filing Released Lang Actions
SynBiotic SE schliet Einbringungsvertrag uber den Erwerb von 50,2 % der Anteile an der greensby UG (haftungsbeschrankt), Vettweiss, ab.
M&A Activity Classification · 95% confidence The document is explicitly labeled as an 'Ad-hoc' announcement and 'Insiderinformation gem. Artikel 17 der Verordnung (EU) Nr. 596/2014' (Insider Information pursuant to Article 17 of Regulation (EU) No 596/2014). The content details the signing of an agreement to acquire 50.2% of another company (greensby UG) and outlines the associated capital increase (Sachkapitalerhöhung) involving the issuance of new shares. This transaction involves a significant corporate action related to financing, capital structure, and M&A activity. Since the core event is the agreement for acquisition contingent on a capital increase, it strongly aligns with 'Capital/Financing Update' (CAP) or 'M&A Activity' (TAR). Given the explicit mention of a capital increase ('Kapitalerhöhung') and the valuation of shares being brought in, CAP is highly relevant. However, the primary driver is the acquisition/takeover aspect. Since the document describes the agreement for an acquisition contingent on a capital increase, and it is an immediate regulatory disclosure (Ad-hoc), it fits best under M&A Activity (TAR) as it is a takeover proposal/agreement, or CAP if the financing aspect is prioritized. Given the structure of the definitions, TAR (M&A Activity) covers merger proposals or takeover bids, which an acquisition agreement falls under. The document is a direct announcement of a transaction, not a report about a past event or a general regulatory filing fallback. I will classify it as TAR.
2024-11-22 German
SYNBIOTIC SE: Frank Otto, Erwerb von Aktien durch Ausubung von Wandlungsrechten aus Wandelschuldverschreibung (ISIN DE000A351VJ4)
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains detailed information regarding a transaction ('Erwerb von Aktien' - Acquisition of shares) by a member of the supervisory board ('Aufsichtsrat'), Frank Otto. This directly corresponds to the definition of Director's Dealing reports, which track personal share transactions by company directors and executives (insider trades). The filing code for this is DIRS.
2024-11-13 German
Company agreement - Satzung - SYNBIOTIC SE
Governance Information Classification · 98% confidence The document text is titled "SATZUNG" (Statutes/Articles of Association) for "SYNBIOTIC SE". It details the company's structure, including its firm name, registered office, business purpose, share capital (Grundkapital), authorized capital (Genehmigtes Kapital), conditional capital (Bedingtes Kapital), and provisions regarding the Management Board (Verwaltungsrat) and Managing Directors (Geschäftsführende Direktoren). This content is fundamental to the company's legal and governance framework. While it relates to governance, the specific nature of amending or establishing the foundational rules points most directly to Governance Information (CGR) or potentially a document related to an AGM/Shareholder meeting where such changes are approved. Since it is the text of the Articles of Association itself, which defines the governance structure, 'Governance Information' (CGR) is the most appropriate classification, as it covers internal rules and board structure. It is not a report (10-K, IR), a release (ER), or a proxy statement (PSI).
2024-11-04 German
SynBiotic SE - Half-year report 2023 HGB (DE | PDF)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Halbjahresbericht' (Half-Year Report) for SynBiotic SE covering the period from January 1, 2023, to June 30, 2023. It contains formal financial statements, specifically a balance sheet (Bilanz) and an income statement (Gewinn- und Verlustrechnung), along with explanatory notes. Since it provides comprehensive financial data for an interim period (less than a full fiscal year), it is classified as an Interim/Quarterly Report. H1 2023
2024-09-28 German
Share price target 12.50 euros: Annual General Meeting supports SYNBIOTIC's growth plans with over 99 percent approval
AGM Information Classification · 99% confidence The document explicitly mentions the 'Annual General Meeting of SYNBIOTIC SE' and details the outcomes of the voting, including the approval of management plans and the election of new board members. The key phrase is 'Annual General Meeting supports SYNBIOTIC’s growth plans with over 99 percent approval'. This directly corresponds to the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting.
2024-09-27 English
SynBiotic SE - Half-year report 2024 HGB (DE | PDF)
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Halbjahresbericht' (Half-Year Report) for the period from January 1, 2024, to June 30, 2024. It contains detailed financial statements, including a balance sheet (Bilanz) and a profit and loss statement (Gewinn- und Verlustrechnung), as well as explanatory notes. Since it covers a period shorter than a full fiscal year and provides substantive financial data, it is classified as an Interim/Quarterly Report. H1 2024
2024-09-27 German

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.